Advertisement
U.S. markets closed
  • S&P 500

    5,254.35
    +5.86 (+0.11%)
     
  • Dow 30

    39,807.37
    +47.29 (+0.12%)
     
  • Nasdaq

    16,379.46
    -20.06 (-0.12%)
     
  • Russell 2000

    2,124.55
    +10.20 (+0.48%)
     
  • Crude Oil

    83.11
    -0.06 (-0.07%)
     
  • Gold

    2,254.80
    +16.40 (+0.73%)
     
  • Silver

    25.10
    +0.18 (+0.74%)
     
  • EUR/USD

    1.0784
    -0.0009 (-0.09%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • dólar/libra

    1.2625
    +0.0003 (+0.03%)
     
  • USD/JPY

    151.3280
    -0.0440 (-0.03%)
     
  • Bitcoin USD

    69,974.51
    -406.88 (-0.58%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • FTSE 100

    7,952.62
    +20.64 (+0.26%)
     
  • Nikkei 225

    40,369.44
    +201.37 (+0.50%)
     

TPT Global Tech's (OTCQB:TPTW) Subsidiary TPT MedTech Signs Contract with Hook Diagnostics and Hook Laboratories to Launch Its Mobile "QuikLAB" Testing, Monitoring, Vaccination APP and Its "QuikPASS" Check and Verify Platform in Southern California

"TPTW, one more milestone to help in the fight against Covid 19"

SAN DIEGO, CA / ACCESSWIRE / January 14, 2021 / TPT Global Tech, Inc. www.tptglobaltech.com ("TPTW or the Company") (OTCQB:TPTW) announced today that its subsidiary TPT MedTech, LLC ("TPT MedTech") www.tptmedtech.com executed a Software as a Service (SaaS) licensing agreement with Hook Diagnostics www.hookdx.com and Hook Labs www.hookdxlabs.com ("Hook DX"). HookDx will be marketing TPT MedTech "QuikLAB" and "QuikPASS" technology platforms as a co-branding partner to its customers domestically, out of their offices in North Carolina and San Diego, and internationally. HookDx will pay TPT Med Tech a monthly software licensing fee as well as a per test transaction fee.

Once the software on-boarding and training activities are complete, TPT MedTech and Hook Dx have a target launch date of January 20, 2021. Hook Dx will on-board its primary laboratory and partners.

TPT MedTech developed its "QuikPass" Check and Verify and Vaccination monitoring platform for Corporations, Government Organizations, Schools, Airlines, Hospitals, Sports Venues, Restaurants, Hotels and Nightclubs to check and verify that an individual has been tested for Covid 19 or Vaccinated providing proof individuals are virus free and able to gain access to venues with the idea that everyone inside that venue would be Covid free. The "QuikPass" "Check and Verify" platform works with third party testing labs and organizations that participate on the "QuikPass" Network and will be offered FREE to US domestic and international business commerce and government organizations around the world.

"Our team is extremely excited to partner with TPT Medtech. By combining our organizations' capabilities, we can achieve population-scale testing. Having QuikLabs and QuikPass along with testing provides a path to safely reopen our communities." Simon Kratzat, President and CEO Hook Diagnostics.

"It is amazing how hard our development teams are working to bring new innovative products to market to help fight against this pandemic. We here at TPTW and TPT MedTech will continue to sort out those missing pieces to the puzzle and develop new products that will help rid our planet of the virus that has changed our lives." said Stephen Thomas, CEO.

About TPT Global Tech
TPT Global Tech Inc. (TPTW) based in San Diego, California, is a technology-based company with divisions providing telecommunications, medical technology and product distribution, media content for domestic and international syndication as well as technology solutions. TPT Global Tech offers Software as a Service (SaaS), Technology Platform as a Service (PAAS), Cloud-based Unified Communication as a Service (UCaaS). It offers carrier-grade performance and support for businesses over its private IP MPLS fiber and wireless network in the United States. TPT's cloud-based UCaaS services allow businesses of any size to enjoy all the latest voice, data, media and collaboration features in today's global technology markets. TPT Global Tech also operates as a Master Distributor for Nationwide Mobile Virtual Network Operators (MVNO) and Independent Sales Organization (ISO) as a Master Distributor for Pre-Paid Cell phone services, Mobile phones Cell phone Accessories and Global Roaming Cell phones.

Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of various provisions of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, commonly identified by such terms as "believes," "looking ahead," "anticipates," "estimates" and other terms with similar meaning. Specifically, statements about the Company's plans for accelerated growth, improved profitability, future business partners, M&A activity, new service offerings, and pursuit of new markets are forward-looking statements. Although the company believes that the assumptions upon which its forward-looking statements are based are reasonable, it can give no assurance that these assumptions will prove to be correct. Such forward-looking statements should not be construed as fact. The information contained in such statements is beyond the ability of the Company to control, and in many cases, the Company cannot predict what factors would cause results to differ materially from those indicated in such statements. All forward-looking statements in the press release are expressly qualified by these cautionary statements and by reference to the underlying assumptions.

Contact:

Frank Benedetto
619-915-9422

SOURCE: TPT Global Tech, Inc.



View source version on accesswire.com:
https://www.accesswire.com/624369/TPT-Global-Techs-OTCQBTPTW-Subsidiary-TPT-MedTech-Signs-Contract-with-Hook-Diagnostics-and-Hook-Laboratories-to-Launch-Its-Mobile-QuikLAB-Testing-Monitoring-Vaccination-APP-and-Its-QuikPASS-Check-and-Verify-Platform-in-Southern-California

Advertisement